Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Astria Therapeutics Inc’s current trading price is -10.60% away from its 52-week high, while its distance from the 52-week low is 252.58%. The stock’s price range over this period has fluctuated between $4.26 and $16.80. The company, operating within the financial sector, had a trading volume of approximately 1.98 million for the day, which was noticeably higher than the average daily share volume of 0.9 million over the last 3 months.
Astria Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $16.80 on 03/25/24, while the lowest price for the same period was registered at $4.26 on 11/17/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Astria Therapeutics Inc (ATXS) has experienced a quarterly rise of 141.09% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 824.60M and boasts a workforce of 59 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.43, with a change in price of +10.28. Similarly, Astria Therapeutics Inc recorded 744,975 in trading volume during the last 100 days, posting a change of +215.97%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ATXS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
ATXS Stock Stochastic Average
Today’s raw stochastic average for Astria Therapeutics Inc over the last 50 days is 81.38%.This indicates a increase from the raw stochastic average of the past 20 days, which was 57.63%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 66.97% and 75.16%, respectively.
ATXS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 95.57%.However, over the last six months, we can see a weaker performance of 114.88%. Over the last 30 days, the price of ATXS has fallen by 16.52%. And in the last five days, it has fallen by -3.78%.
